US 10364238
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
granted A61KA61K31/4439A61K31/445
Quick answer
US patent 10364238 (N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors) held by KalVista Pharmaceuticals Limited expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4439, A61K31/445, A61K31/496, A61P